IL-7 Immunotherapy in a Nonimmunocompromised Patient With Intractable Fungal Wound Sepsis
Isaiah R. Turnbull(Washington University in St. Louis), Richard S. Hotchkiss(Washington University in St. Louis), Jennifer Leonard(Washington University in St. Louis), Andrej Spec(Washington University in St. Louis), Carlos Mejía-Chew(Washington University in St. Louis), John P. Kirby(Washington University in St. Louis), Mark H. Hoofnagle(Washington University in St. Louis), Joseph P. Gaut(Washington University in St. Louis), Kenneth E. Remy(Washington University in St. Louis), Robert F. Potter(Children's Hospital of Philadelphia), Sydney Miles(Washington University in St. Louis), Monty B. Mazer(Rainbow Babies & Children's Hospital), Eric M. Ransom(Case Western Reserve University), Jane Blood(Washington University in St. Louis)
Cited by 27
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Sepsis and septic shock
|Nature Reviews Disease Primers|2016|1.6k
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
|JCI Insight|2018|412
Immunotherapy for Sepsis — A New Approach against an Ancient Foe
|New England Journal of Medicine|2010|367
Accelerated Lymphocyte Death in Sepsis Occurs by both the Death Receptor and Mitochondrial Pathways
|The Journal of Immunology|2005|338